{"version":"1.0","provider_name":"Theramex Belgium Dutch (NL-BE)","provider_url":"https:\/\/www.theramex.com\/nl-be","author_name":"Mollie Neal","author_url":"https:\/\/www.theramex.com\/nl-be\/nieuws\/author\/mollie-neal\/","title":"Theramex launches Livogiva\u00ae, a new teriparatide pre-filled pen for the treatment of severe osteoporosis - Theramex Belgium Dutch (NL-BE)","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"OkojjMI4s1\"><a href=\"https:\/\/www.theramex.com\/nl-be\/nieuws\/theramex-launches-livogiva\/\">Theramex launches Livogiva\u00ae, a new teriparatide pre-filled pen for the treatment of severe osteoporosis<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.theramex.com\/nl-be\/nieuws\/theramex-launches-livogiva\/embed\/#?secret=OkojjMI4s1\" width=\"600\" height=\"338\" title=\"&#8220;Theramex launches Livogiva\u00ae, a new teriparatide pre-filled pen for the treatment of severe osteoporosis&#8221; &#8212; Theramex Belgium Dutch (NL-BE)\" data-secret=\"OkojjMI4s1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.theramex.com\/nl-be\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"London, January 18 2021: Theramex has today launched Livogiva\u00ae to patients in Europe for the first time. The treatment has been launched initially in Germany, with availability in other EU countries soon to follow \u2013 including France, Italy and Spain. Livogiva is a new presentation of teriparatide, the only bone anabolic treatment for osteoporosis, which [&hellip;]"}